Search Results - "KY, Bonnie"

Sex differences in heart failure by Lam, Carolyn S P, Arnott, Clare, Beale, Anna L, Chandramouli, Chanchal, Hilfiker-Kleiner, Denise, Kaye, David M, Ky, Bonnie, Santema, Bernadet T, Sliwa, Karen, Voors, Adriaan A

“…The overall lifetime risk of heart failure (HF) is similar between men and women, however, there are marked sex differences in the landscape of this condition…”
Get full text

Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging by Plana, Juan Carlos, MD, FASE, Chair, Galderisi, Maurizio, MD, FESC, Co-Chair, Barac, Ana, MD, PhD, Ewer, Michael S., MD, JD, Ky, Bonnie, MD, FASE, Scherrer-Crosbie, Marielle, MD, PhD, FASE, Ganame, Javier, MD, PhD, FASE, Sebag, Igal A., MD, FASE, Agler, Deborah A., RCT, RDCS, FASE, Badano, Luigi P., MD, PhD, FESC, Banchs, Jose, MD, FASE, Cardinale, Daniela, MD, PhD, FESC, Carver, Joseph, MD, Cerqueira, Manuel, MD, DeCara, Jeanne M., MD, FASE, Edvardsen, Thor, MD, PhD, FESC, Flamm, Scott D., MD, MBA, Force, Thomas, MD, Griffin, Brian P., MD, Jerusalem, Guy, MD, PhD, Liu, Jennifer E., MD, FASE, Magalhães, Andreia, MD, Marwick, Thomas, MBBS, PhD, MPH, Sanchez, Liza Y., RCS, FASE, Sicari, Rosa, MD, PhD, FESC, Villarraga, Hector R., MD, FASE, Lancellotti, Patrizio, MD, PhD, FESC

Get full text

Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study by Armenian, Saro H, Xu, Lanfang, Ky, Bonnie, Sun, Canlan, Farol, Leonardo T, Pal, Sumanta Kumar, Douglas, Pamela S, Bhatia, Smita, Chao, Chun

“…Cardiovascular diseases (CVDs), including ischemic heart disease, stroke, and heart failure, are well-established late effects of therapy in survivors of…”
Get full text

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline by Armenian, Saro H, Lacchetti, Christina, Barac, Ana, Carver, Joseph, Constine, Louis S, Denduluri, Neelima, Dent, Susan, Douglas, Pamela S, Durand, Jean-Bernard, Ewer, Michael, Fabian, Carol, Hudson, Melissa, Jessup, Mariell, Jones, Lee W, Ky, Bonnie, Mayer, Erica L, Moslehi, Javid, Oeffinger, Kevin, Ray, Katharine, Ruddy, Kathryn, Lenihan, Daniel

“…Purpose Cardiac dysfunction is a serious adverse effect of certain cancer-directed therapies that can interfere with the efficacy of treatment, decrease…”
Get full text

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement by Herrmann, Joerg, Lenihan, Daniel, Armenian, Saro, Barac, Ana, Blaes, Anne, Cardinale, Daniela, Carver, Joseph, Dent, Susan, Ky, Bonnie, Lyon, Alexander R, López-Fernández, Teresa, Fradley, Michael G, Ganatra, Sarju, Curigliano, Giuseppe, Mitchell, Joshua D, Minotti, Giorgio, Lang, Ninian N, Liu, Jennifer E, Neilan, Tomas G, Nohria, Anju, O'Quinn, Rupal, Pusic, Iskra, Porter, Charles, Reynolds, Kerry L, Ruddy, Kathryn J, Thavendiranathan, Paaladinesh, Valent, Peter

“…Abstract The discipline of Cardio-Oncology has seen tremendous growth over the past decade. It is devoted to the cardiovascular (CV) care of the cancer…”
Get full text

Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies by Hahn, Virginia Shalkey, Lenihan, Daniel J., Ky, Bonnie

Get full text

Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology by Pudil, Radek, Mueller, Christian, Čelutkienė, Jelena, Henriksen, Peter A., Lenihan, Dan, Dent, Susan, Barac, Ana, Stanway, Susanna, Moslehi, Javid, Suter, Thomas M., Ky, Bonnie, Štěrba, Martin, Cardinale, Daniela, Cohen‐Solal, Alain, Tocchetti, Carlo Gabriele, Farmakis, Dimitrios, Bergler‐Klein, Jutta, Anker, Markus S., Von Haehling, Stephan, Belenkov, Yury, Iakobishvili, Zaza, Maack, Christoph, Ciardiello, Fortunato, Ruschitzka, Frank, Coats, Andrew J.S., Seferovic, Petar, Lainscak, Mitja, Piepoli, Massimo F., Chioncel, Ovidiu, Bax, Jereon, Hulot, Jean‐Sebastien, Skouri, Hadi, Hägler‐Laube, Eva Simona, Asteggiano, Riccardo, Fernandez, Teresa Lopez, Boer, Rudolf A., Lyon, Alexander R.

“…Serum biomarkers are an important tool in the baseline risk assessment and diagnosis of cardiovascular disease in cancer patients receiving cardiotoxic cancer…”
Get full text

Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients by Sawaya, Heloisa, MD, PhD, Sebag, Igal A., MD, Plana, Juan Carlos, MD, Januzzi, James L., MD, Ky, Bonnie, MD, Cohen, Victor, MD, Gosavi, Sucheta, MD, Carver, Joseph R., MD, Wiegers, Susan E., MD, Martin, Randolph P., MD, Picard, Michael H., MD, Gerszten, Robert E., MD, Halpern, Elkan F., PhD, Passeri, Jonathan, MD, Kuter, Irene, MD, Scherrer-Crosbie, Marielle, MD, PhD

“…As breast cancer survival increases, cardiotoxicity associated with chemotherapeutic regimens such as anthracyclines and trastuzumab becomes a more significant…”
Get full text

Ventricular-Arterial Coupling, Remodeling, and Prognosis in Chronic Heart Failure by Ky, Bonnie, MD, MSCE, French, Benjamin, PhD, May Khan, Abigail, MD, Plappert, Ted, CVT, Wang, Andrew, BA, Chirinos, Julio A., MD, Fang, James C., MD, Sweitzer, Nancy K., MD, PhD, Borlaug, Barry A., MD, Kass, David A., MD, St. John Sutton, Martin, MBBS, Cappola, Thomas P., MD, ScM

“…Objectives The objective of this study was to compare the physiological determinants of ejection fraction (EF)—ventricular size, contractile function, and…”
Get full text

Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma by Cornell, Robert F, Ky, Bonnie, Weiss, Brendan M, Dahm, Cherie N, Gupta, Deepak K, Du, Liping, Carver, Joseph R, Cohen, Adam D, Engelhardt, Brian G, Garfall, Alfred L, Goodman, Stacey A, Harrell, Shelton Lacy, Kassim, Adetola A, Jadhav, Trafina, Jagasia, Madan, Moslehi, Javid, O'Quinn, Rupal, Savona, Michael R, Slosky, David, Smith, Amanda, Stadtmauer, Edward A, Vogl, Dan T, Waxman, Adam, Lenihan, Daniel

“…Cardiovascular adverse events (CVAEs) can occur during proteasome inhibitor (PI) therapy. We conducted a prospective, observational, multi-institutional study…”
Get full text

Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab by Ky, Bonnie, MD, MSCE, Putt, Mary, ScD, Sawaya, Heloisa, MD, PhD, French, Benjamin, PhD, Januzzi, James L., MD, Sebag, Igal A., MD, Plana, Juan Carlos, MD, Cohen, Victor, MD, Banchs, Jose, MD, Carver, Joseph R., MD, Wiegers, Susan E., MD, Martin, Randolph P., MD, Picard, Michael H., MD, Gerszten, Robert E., MD, Halpern, Elkan F., PhD, Passeri, Jonathan, MD, Kuter, Irene, MD, Scherrer-Crosbie, Marielle, MD, PhD

“…Objectives The aim of this study was to determine if individual or multiple biomarkers are associated with cardiotoxicity in patients with breast cancer…”
Get full text

Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children's Oncology Group by Getz, Kelly D, Sung, Lillian, Ky, Bonnie, Gerbing, Robert B, Leger, Kasey J, Leahy, Allison Barz, Sack, Leah, Woods, William G, Alonzo, Todd, Gamis, Alan, Aplenc, Richard

“…Late cardiotoxicity after pediatric acute myeloid leukemia therapy causes substantial morbidity and mortality. The impact of early-onset cardiotoxicity on…”
Get full text

Preparing the Cardiovascular Workforce to Care for Oncology Patients by Hayek, Salim S., Ganatra, Sarju, Lenneman, Carrie, Scherrer-Crosbie, Marielle, Leja, Monika, Lenihan, Daniel J., Yang, Eric, Ryan, Thomas D., Liu, Jennifer, Carver, Joseph, Mousavi, Negareh, O’Quinn, Rupal, Arnold, Anita, Banchs, Jose, Barac, Ana, Ky, Bonnie

“…Cardiovascular disease and cancer are the 2 main causes of death in the United States. They intersect on multiple levels, sharing common causal mechanisms and…”
Get full text

ST2 and Patient Prognosis in Chronic Heart Failure by Bayes-Genis, Antoni, MD, PhD, Zhang, Yuhui, MD, Ky, Bonnie, MD, MSCE

“…Biomarkers of cardiovascular diseases are indispensable tools for diagnosis and prognosis, and the use of several biomarkers is now considered the standard of…”
Get full text

Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma by Narayan, Vivek, Keefe, Stephen, Haas, Naomi, Wang, Le, Puzanov, Igor, Putt, Mary, Catino, Anna, Fang, James, Agarwal, Neeraj, Hyman, David, Smith, Amanda M, Finkelman, Brian S, Narayan, Hari K, Ewer, Steven, ElAmm, Chantal, Lenihan, Daniel, Ky, Bonnie

“…To prospectively evaluate cardiotoxicity risk with sunitinib in metastatic renal cell carcinoma (mRCC) routine clinical practice using comprehensive…”
Get full text

A randomized dose‐response trial of aerobic exercise and health‐related quality of life in colon cancer survivors by Brown, Justin C., Damjanov, Nevena, Courneya, Kerry S., Troxel, Andrea B., Zemel, Babette S., Rickels, Michael R., Ky, Bonnie, Rhim, Andrew D., Rustgi, Anil K., Schmitz, Kathryn H.

“…Objective To examine the dose‐response effects of aerobic exercise on health‐related quality of life (HRQoL) among colon cancer survivors. Methods Thirty‐nine…”
Get full text

Patterns of Cardiac Toxicity Associated With Irreversible Proteasome Inhibition in the Treatment of Multiple Myeloma by Grandin, E. Wilson, MD, MPH, Ky, Bonnie, MD, MSCE, Cornell, R. Frank, MD, Carver, Joseph, MD, Lenihan, Daniel J., MD

“…Abstract Carfilzomib is a novel irreversible proteasome inhibitor (PI) used with increasing frequency to treat patients with relapsed and/or refractory…”
Get full text

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction by Demissei, Biniyam G, Hubbard, Rebecca A, Zhang, Liyong, Smith, Amanda M, Sheline, Karyn, McDonald, Caitlin, Narayan, Vivek, Domchek, Susan M, DeMichele, Angela, Shah, Payal, Clark, Amy S, Fox, Kevin, Matro, Jennifer, Bradbury, Angela R, Knollman, Hayley, Getz, Kelly D, Armenian, Saro H, Januzzi, James L, Tang, W H Wilson, Liu, Peter, Ky, Bonnie

“…Background We examined the longitudinal associations between changes in cardiovascular biomarkers and cancer therapy-related cardiac dysfunction (CTRCD) in…”
Get full text

Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial by Kawut, Steven M, Archer-Chicko, Christine L, DeMichele, Angela, Fritz, Jason S, Klinger, James R, Ky, Bonnie, Palevsky, Harold I, Palmisciano, Amy J, Patel, Mamta, Pinder, Diane, Propert, Kathleen J, Smith, K Akaya, Stanczyk, Frank, Tracy, Russell, Vaidya, Anjali, Whittenhall, Mary E, Ventetuolo, Corey E

“…The aromatase inhibitor anastrozole blocks the conversion of androgens to estrogen and blunts pulmonary hypertension in animals, but its efficacy in treating…”
Get full text

Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics–Related Cardiac Dysfunction by Narayan, Hari K., MD, French, Benjamin, PhD, Khan, Abigail M., MD, Plappert, Theodore, RCVS, Hyman, David, BA, Bajulaiye, Akinyemi, BA, Domchek, Susan, MD, DeMichele, Angela, MD, MSCE, Clark, Amy, MD, MSCE, Matro, Jennifer, MD, Bradbury, Angela, MD, Fox, Kevin, MD, Carver, Joseph R., MD, Ky, Bonnie, MD, MSCE

“…Abstract Objectives This study sought to determine the relationships between echocardiography-derived measures of myocardial mechanics and cancer…”
Get full text